“…[ 4 ] This case highlights the importance of distinguishing true ischemic stroke that may exhibit metabolic activity in subacute phase from malignant brain tumors, such as gliomas, meningiomas, metastases, and uncommon lesions such as intravascular lymphoma, that can masquerade as acute stroke. [ 5 6 7 ] The above metabolic pattern of hypometabolic ischemic core and the surrounding hypermetabolic active inflammatory phase of subacute ischemic stroke representing viable tissues in the ischemic penumbra is attributable to the upregulation of parenchymal and microvascular glucose transporters (GLUTs), lateralization of GLUT1 mRNA expression to the ischemic hemisphere,[ 8 ] and “trapping” of 18 F-FDG-6-phosphate due to increased hexokinase activity in the peri-ischemic regions in response to hypoxia. The discrimination between brain tumors mimicking stroke and a true ischemic stroke is, therefore, crucial for proper management.…”